Chennai: Dr Reddy’s Laboratories Ltd has announced that Reddy-Lenalidomide,a genericequivalent to Revlimid (lenalidomide) capsules, is approved by Health Canada and has been launched in the Canadian market.
Reddy-Lenalidomide is one of the first generic medications of its kind to launch in Canada, it said.
“Our launch of Reddy-Lenalidomide represents our firm commitment to providing access to affordable medicines for Canada’s Multiple Myeloma and Myelodysplastic Syndrome (MDS) patient population,” said Vinod Ramachandran, vice president and general manager, Dr Reddy’s Laboratories Canada.